Ontology highlight
ABSTRACT:
SUBMITTER: Bonner LA
PROVIDER: S-EPMC3515654 | biostudies-literature | 2011 Jun
REPOSITORIES: biostudies-literature
ChemMedChem 20110428 6
A novel class of isochroman dopamine analogues, originally reported by Abbott Laboratories, have >100-fold selectivity for D₁-like over D₂-like receptors. We synthesized a parallel series of chroman compounds and showed that repositioning the oxygen atom in the heterocyclic ring decreases potency and confers D₂-like receptor selectivity to these compounds. In silico modeling supports the hypothesis that the altered pharmacology for the chroman series is due to potential intramolecular hydrogen b ...[more]